Drug control: a prerequisite for health

Area of Science:

• Health Economics
• Pharmaceutical Policy
• Global Health

Background:

• Rising drug expenditures significantly burden health budgets in many developing countries.
• Disproportionate spending on expensive, low-benefit drugs in urban centers exacerbates resource scarcity for primary care and rural populations.

Purpose of the Study:

• To analyze the impact of drug spending on health budgets in developing nations.
• To explore strategies for controlling drug costs and improving access to essential medicines.

Main Methods:

• Review of health expenditure patterns, focusing on drug procurement in Third World countries.
• Analysis of policy interventions such as essential drug lists, tendering, and local drug manufacturing.

Main Results:

• Drug spending is heavily concentrated in urban hospitals, favoring costly proprietary medications.
• Limited funds result in unavailability of crucial vaccines and primary care drugs, particularly in rural regions.

Conclusions:

• Implementing essential drug lists and cost-control measures like tendering and local production is crucial for appropriate healthcare policies.
• These cost-containment strategies face significant resistance but are vital for equitable drug access and healthcare system sustainability.